Executive Series - Oventus Medical (OVN) Clinical Director & Co-Founder, Dr Chris Hart

CommSec

CommSec's Tom Piotrowski speaks with Oventus Medical (OVN) Clinical Director & Co-Founder, Dr Chris Hart about:

  • OVN’s Airway Technology and how it compares to Continuous Positive Airway Pressure (CPAP) devices which are commonly used to treat individual suffering from obstructive sleep apnoea and problem snoring.
  • OVN’s plans for the commercial rollout of its O2Vent product following FDA clearance, which will see exclusive distribution in the US by OVN’s distribution partner Modern Dental – which covers approximately one quarter of US dentists through 34,000 dental offices.

Youtube Link:

To view more Executive Series interviews, visit:

https://www.commsec.com.au/market-news/executive-series.html


Comments

Please sign in to comment on this wire.